tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX

Tenax Therapeutics (TENX) Financial Statements

471 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently ―. The company's EPS TTM is $-111.688; its P/E ratio is -0.03; Tenax Therapeutics is scheduled to report earnings on April 3, 2023, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue---$ 0.00$ 0.00
Gross Profit-----
EBIT$ -1.10M$ -1.40M$ -2.54M$ -2.92M$ -2.86M
EBITDA$ -1.10M$ -1.40M$ -2.51M$ -2.89M$ -2.83M
Net Income Common Stockholders$ -1.11M$ -1.41M$ -2.55M$ -2.92M$ -2.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.39M$ 14.41M$ 2.12M$ 3.81M$ 7.23M
Total Assets$ 14.05M$ 15.27M$ 3.40M$ 4.74M$ 8.36M
Total Debt$ 345.75K$ 513.91K$ 688.50K$ 211.59K$ 330.91K
Net Debt$ -13.05M$ -13.90M$ -1.44M$ -3.59M$ -6.90M
Total Liabilities$ 823.84K$ 993.86K$ 1.91M$ 785.17K$ 1.57M
Stockholders Equity$ 13.22M$ 14.28M$ 1.49M$ 3.95M$ 6.78M
Cash Flow-
Free Cash Flow$ -924.57K$ -1.73M$ -2.31M$ -3.33M$ -3.43M
Operating Cash Flow$ -922.97K$ -1.72M$ -2.31M$ -3.33M$ -3.43M
Investing Cash Flow$ 1.60K$ 1.24K$ 4.00K$ 0.00$ 0.00
Financing Cash Flow$ -99.91K$ 14.01M$ 626.37K$ -91.88K$ 7.79M
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Tenax Therapeutics Debt to Assets

Tenax Therapeutics Cash Flow

Tenax Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis